BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9887531)

  • 1. Curacin D, an antimitotic agent from the marine cyanobacterium Lyngbya majuscula.
    Márquez B; Verdier-Pinard P; Hamel E; Gerwick WH
    Phytochemistry; 1998 Dec; 49(8):2387-9. PubMed ID: 9887531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthetic pathway and gene cluster analysis of curacin A, an antitubulin natural product from the tropical marine cyanobacterium Lyngbya majuscula.
    Chang Z; Sitachitta N; Rossi JV; Roberts MA; Flatt PM; Jia J; Sherman DH; Gerwick WH
    J Nat Prod; 2004 Aug; 67(8):1356-67. PubMed ID: 15332855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula.
    Milligan KE; Marquez BL; Williamson RT; Gerwick WH
    J Nat Prod; 2000 Oct; 63(10):1440-3. PubMed ID: 11076574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curacin E from the Brittle Star Ophiocoma scolopendrina.
    Ueoka R; Hitora Y; Ito A; Yoshida M; Okada S; Takada K; Matsunaga S
    J Nat Prod; 2016 Oct; 79(10):2754-2757. PubMed ID: 27684202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and structure of the cytotoxin lyngbyabellin B and absolute configuration of lyngbyapeptin A from the marine cyanobacterium Lyngbya majuscula.
    Luesch H; Yoshida WY; Moore RE; Paul VJ
    J Nat Prod; 2000 Oct; 63(10):1437-9. PubMed ID: 11076573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barbamide, a chlorinated metabolite with molluscicidal activity from the Caribbean cyanobacterium Lyngbya majuscula.
    Orjala J; Gerwick WH
    J Nat Prod; 1996 Apr; 59(4):427-30. PubMed ID: 8699186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysideaprolines A-F and barbaleucamides A-B, novel polychlorinated compounds from a Dysidea species.
    Harrigan GG; Goetz GH; Luesch H; Yang S; Likos J
    J Nat Prod; 2001 Sep; 64(9):1133-8. PubMed ID: 11575943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grenadadiene and grenadamide, cyclopropyl-containing fatty acid metabolites from the marine cyanobacterium Lyngbya majuscula.
    Sitachitta N; Gerwick WH
    J Nat Prod; 1998 May; 61(5):681-4. PubMed ID: 9599279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Besarhanamides A and B from the marine cyanobacterium Lyngbya majuscula.
    Tan LT; Chang YY; Ashootosh T
    Phytochemistry; 2008 Jul; 69(10):2067-9. PubMed ID: 18514238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogues.
    Blokhin AV; Yoo HD; Geralds RS; Nagle DG; Gerwick WH; Hamel E
    Mol Pharmacol; 1995 Sep; 48(3):523-31. PubMed ID: 7565634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lyngbyastatin 2 and norlyngbyastatin 2, analogues of dolastatin G and nordolastatin G from the marine cyanobacterium Lyngbya majuscula.
    Luesch H; Yoshida WY; Moore RE; Paul VJ
    J Nat Prod; 1999 Dec; 62(12):1702-6. PubMed ID: 10654420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmyramide A, a cyclic depsipeptide from a Palmyra Atoll collection of the marine cyanobacterium Lyngbya majuscula.
    Taniguchi M; Nunnery JK; Engene N; Esquenazi E; Byrum T; Dorrestein PC; Gerwick WH
    J Nat Prod; 2010 Mar; 73(3):393-8. PubMed ID: 19839606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.
    Verdier-Pinard P; Lai JY; Yoo HD; Yu J; Marquez B; Nagle DG; Nambu M; White JD; Falck JR; Gerwick WH; Day BW; Hamel E
    Mol Pharmacol; 1998 Jan; 53(1):62-76. PubMed ID: 9443933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malevamide D: isolation and structure determination of an isodolastatin H analogue from the marine cyanobacterium Symploca hydnoides.
    Horgen FD; Kazmierski EB; Westenburg HE; Yoshida WY; Scheuer PJ
    J Nat Prod; 2002 Apr; 65(4):487-91. PubMed ID: 11975485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apramides A-G, novel lipopeptides from the marine cyanobacterium Lyngbya majuscula.
    Luesch H; Yoshida WY; Moore RE; Paul VJ
    J Nat Prod; 2000 Aug; 63(8):1106-12. PubMed ID: 10978206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antillatoxin B, a neurotoxic lipopeptide from the marine cyanobacterium Lyngbya majuscula.
    Nogle LM; Okino T; Gerwick WH
    J Nat Prod; 2001 Jul; 64(7):983-5. PubMed ID: 11473443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitipeptolides A and B, new cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula.
    Luesch H; Pangilinan R; Yoshida WY; Moore RE; Paul VJ
    J Nat Prod; 2001 Mar; 64(3):304-7. PubMed ID: 11277744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hermitamides A and B, toxic malyngamide-type natural products from the marine cyanobacterium Lyngbya majuscula.
    Tan LT; Okino T; Gerwick WH
    J Nat Prod; 2000 Jul; 63(7):952-5. PubMed ID: 10924172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carmabins A and B, new lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula.
    Hooper GJ; Orjala J; Schatzman RC; Gerwick WH
    J Nat Prod; 1998 Apr; 61(4):529-33. PubMed ID: 9584405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nhatrangins A and B, aplysiatoxin-related metabolites from the marine cyanobacterium Lyngbya majuscula from Vietnam.
    Chlipala GE; Pham HT; Nguyen VH; Krunic A; Shim SH; Soejarto DD; Orjala J
    J Nat Prod; 2010 Apr; 73(4):784-7. PubMed ID: 20373744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.